
|Videos|February 15, 2023
Case 1: Faricimab in a high-need neovascular nAMD patient
Advertisement
Dr. Khanani shares the case of a neovascular nAMD patient with high disease activity who achieved significant vision improvement and fluid resolution after switching to faricimab.
Sponsored by Roche
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
















































